MCT-1 Antibody Blocking peptide
MCT-1 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Malignant T-cell-amplified sequence 1, MCT-1, Multiple copies T-cell malignancies, MCTS1, MCT1
UniProt
Q9ULC4
Field of Research
Cancer, DNA Damage, Epigenetics
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1929909 was selected from the N-term region of human MCT-1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog